Comparative Pharmacology
Head-to-head clinical analysis: HIBICLENS versus HIBISTAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HIBICLENS versus HIBISTAT.
HIBICLENS vs HIBISTAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged cell wall components, causing leakage of cytoplasmic contents and precipitation of proteins. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria, fungi, and some viruses.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Active against susceptible gram-positive bacteria.
Apply 5 mL to wet skin, lather, and rinse thoroughly after 1 minute. For preoperative showering, use 5 mL twice daily for 2 days before surgery. For surgical scrub, brush 5 mL for 2 minutes, then rinse. For hand wash, use 5 mL for 15 seconds.
1.5 mg/kg intravenously every 6 hours; maximum 120 mg per dose.
None Documented
None Documented
Not applicable due to negligible systemic absorption; topical application results in skin retention with minimal systemic exposure.
Terminal elimination half-life is 2.5–3.5 hours in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Renal: <1% unchanged; fecal: >99% as chlorhexidine; biliary: negligible.
Approximately 90% of absorbed dose excreted renally as unchanged drug; <5% in feces via biliary elimination.
Category C
Category C
Antiseptic
Antiseptic